Literature DB >> 16706826

Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.

Rumi Mifuji1, Yoshinao Kobayashi, Ning Ma, Qin Li Qiang, Naohito Urawa, Shinichiro Horiike, Motoh Iwasa, Masahiko Kaito, Fabio Malavasi, Yukihiko Adachi.   

Abstract

BACKGROUND AND AIM: Iron deposition in the liver is a common finding in patients with chronic hepatitis C (CH-C). The mechanism of this hepatic accumulation of iron is not completely understood. This study assessed if the protein expression of transferrin receptor 2 (TfR2) is upregulated in the liver of patients with CH-C and if TfR2 protein mediates iron accumulation during hepatitis C virus (HCV) infection.
METHOD: Liver specimens from patients with CH-C that underwent interferon (IFN) therapy (n=23) and from patients with CH-B (n=18) were evaluated. Hepatic expression of TfR2 protein was analyzed by immunohistochemistry. Total hepatic iron score (THIS) was evaluated by Prussian blue staining.
RESULTS: TfR2 protein was expressed in the cell membrane and cytosol of hepatocytes. Cytosol TfR2 protein was found to co-localize with Tf. THIS (P=0.0198) and hepatic TfR2 (P=0.0047) expression were significantly higher in CH-C than in CH-B. The change in THIS values (rho=0.580, P=0.0079) and the grade of histological activity (rho=0.444, P=0.0373) were significantly correlated with changes in TfR2 expression after IFN therapy.
CONCLUSIONS: The protein expression of TfR2 is significantly associated with iron deposition in the liver in patients with CH-C. HCV infection may affect the hepatic expression of TfR2, leading to iron accumulation in the liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706826     DOI: 10.1111/j.1440-1746.2005.04151.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

Review 1.  [Current problems of hepatitis].

Authors:  H P Dienes; U Drebber
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

2.  Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C.

Authors:  Takashi Himoto; Hirohito Yoneyama; Akihiro Deguch; Kazutaka Kurokohchi; Michio Inukai; Hisashi Masugata; Fuminori Goda; Shoichi Senda; Seishiro Watanabe; Satoru Kubota; Shigeki Kuriyama; Tsutomu Masaki
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

3.  Histone Deacetylase 3 Inhibitor Suppresses Hepatitis C Virus Replication by Regulating Apo-A1 and LEAP-1 Expression.

Authors:  Yuan Zhou; Qian Wang; Qi Yang; Jielin Tang; Chonghui Xu; Dongwei Gai; Xinwen Chen; Jizheng Chen
Journal:  Virol Sin       Date:  2018-10-17       Impact factor: 4.327

Review 4.  Mitochondrial iron metabolism and its role in neurodegeneration.

Authors:  Maxx P Horowitz; J Timothy Greenamyre
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance.

Authors:  Yutaka Kohgo; Katsuya Ikuta; Takaaki Ohtake; Yoshihiro Torimoto; Junji Kato
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 6.  Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer.

Authors:  Hongbo Wang; Zaiming Lu; Xiangxuan Zhao
Journal:  J Hematol Oncol       Date:  2019-12-09       Impact factor: 17.388

Review 7.  HCV and oxidative stress in the liver.

Authors:  Alexander V Ivanov; Birke Bartosch; Olga A Smirnova; Maria G Isaguliants; Sergey N Kochetkov
Journal:  Viruses       Date:  2013-01-28       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.